Selectis Health, Inc.
GBCS
$3.10
$0.134.38%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 0.00 | 161.00K |
| Total Other Revenue | 38.24M | 41.44M | 42.17M | 41.34M | 40.33M |
| Total Revenue | 38.24M | 41.44M | 42.17M | 41.34M | 40.49M |
| Cost of Revenue | 29.75M | 31.76M | 32.62M | 31.68M | 30.94M |
| Gross Profit | 8.50M | 9.68M | 9.54M | 9.66M | 9.55M |
| SG&A Expenses | 9.46M | 9.77M | 9.36M | 10.34M | 10.49M |
| Depreciation & Amortization | 1.44M | 1.47M | 1.45M | 1.46M | 1.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.65M | 43.01M | 43.43M | 43.48M | 42.94M |
| Operating Income | -2.41M | -1.56M | -1.27M | -2.14M | -2.45M |
| Income Before Tax | 6.58M | -1.01M | -788.10K | -3.15M | -2.05M |
| Income Tax Expenses | 410.50K | 800.00 | -- | -- | -- |
| Earnings from Continuing Operations | 6.17 | -1.02 | -0.79 | -3.15 | -2.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.17M | -1.02M | -788.10K | -3.15M | -2.05M |
| EBIT | -2.41M | -1.56M | -1.27M | -2.14M | -2.45M |
| EBITDA | -960.80K | -90.20K | 187.00K | -678.30K | -945.20K |
| EPS Basic | 2.00 | -0.34 | -0.27 | -1.04 | -0.68 |
| Normalized Basic EPS | -0.66 | -0.39 | -0.39 | -0.73 | -0.87 |
| EPS Diluted | 1.77 | -0.35 | -0.28 | -1.05 | -0.69 |
| Normalized Diluted EPS | -0.62 | -0.39 | -0.39 | -0.73 | -0.87 |
| Average Basic Shares Outstanding | 12.27M | 12.27M | 12.27M | 12.27M | 12.27M |
| Average Diluted Shares Outstanding | 12.64M | 12.27M | 12.27M | 12.27M | 12.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.02% | -0.10% | -- | -- | -- |